Recent Articles from GlobeNewswire

Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com

New multi-carrier transport network connects the Midwest to major data center hubs, reinforcing the region’s role in next-generation connectivity

Company Advances Enterprise AI Governance Strategy as AI Labor Deployment Expands Across Regulated Industries

Expanded Footprint Underscores Industry Confidence in Expion360's Certified, High-Performance Lithium Battery Technology

Geleen, May 19th, 2026

GF deepens its engagement with the startup ecosystem, partnering with experienced technology leaders to support next wave of AI data center and Physical AI technologies

PodcastOne Acquires Distribution Rights to KILLR Network Show Dude Dads and It’s Library of Over 280 Episodes

CHESTERBROOK, Pa., May 19, 2026 (GLOBE NEWSWIRE) -- Vishay Precision Group, Inc. (NYSE: VPG), a leader in precision measurement and sensing technologies, today announced that William M. Clancy, its Executive Vice President and Chief Financial Officer, will be retiring effective December 31, 2026, and that the Company’s Board of Directors will be conducting a search for his successor.

SINGAPORE, May 19, 2026 (GLOBE NEWSWIRE) -- GCL Global Holdings Ltd (Nasdaq: GCL) (“GCL” or the “Company”), a leading provider of games and entertainment, today announced that its publishing subsidiary, 4Divinity Pte. Ltd. (“4Divinity”), has received an additional $10.0 million strategic investment from ADATA Technology Co., Ltd. (“ADATA”), a world leader in memory and storage solutions, following ADATA’s initial investments of $3.0 million announced in December 2025 and $10.0 million announced in January 2026. The investment provides 4Divinity with the capital to continue securing high-profile global game titles, enhancing its digital distribution infrastructure, and strengthening its position as a leading game publisher in the international market.

Significant Valerus platform order through a long-standing international integration partner

BEIJING, May 19, 2026 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (NASDAQ: HAO; “we” or the “Company”), today announced that it will effect a reverse share split of its outstanding Class A ordinary shares, par value $0.0025 per share (the “Class A Ordinary Shares”) and Class B ordinary shares, par value $0.0025 per share (the “Class B Ordinary Shares”), at a ratio of 1-for-128.

RESTON, Va., May 19, 2026 (GLOBE NEWSWIRE) -- Science Applications International Corp. (NASDAQ: SAIC) is scheduled to issue its first quarter fiscal year 2027 results before market open on Monday, June 1, 2026. SAIC executive management will discuss operational and financial results in a conference call beginning at 10:00 a.m. EDT, following the issuance of the company’s earnings press release. 

BEDFORD, Mass., May 19, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, announced data to be featured at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 29 – June 2, 2026 in Chicago, IL.

Acquisition gives Nexalin control of AI-integrated remote patient-monitoring, clinical data-capture and virtual-care infrastructure already deployed at UCSD

NEW HOPE, Pa., May 19, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced that company management will be participating in the Jefferies Global Healthcare Conference.

Agreement follows Cibolo Health’s endorsement of MyoVista Insights for its network of 127 independent hospitals and reflects continued commercial momentum for HeartSciences’ ECG management platform

New Production Line Expected to Recover Copper, Nickel, Gold, and Silver from Industrial Hazardous Waste Streams

BOSTON, May 19, 2026 (GLOBE NEWSWIRE) -- NodThera, the leading clinical-stage NLRP3 company developing a portfolio of potentially best-in-class brain-penetrant oral NLRP3 inhibitors to address inflammatory drivers of cardiometabolic and neurologic diseases, today announced that data from the cardiometabolic Phase 1b clinical trial of its lead candidate, ruvonoflast, previously known as NT-0796, has been accepted for a late-breaking oral presentation at the 94th European Atherosclerosis Society (EAS) Congress being held May 24-27, 2026 in Athens, Greece.

The new NordStellar AI assistant connects threat intelligence with AI tools, making threat exposure analysis quicker and more accessible

SHANGHAI, May 19, 2026 (GLOBE NEWSWIRE) -- Risen Pharma, a clinical-stage biotech company focusing on the development and commercialization of high-need, patient-accessible therapeutics, today announced the initiation of a Phase 2 clinical study in China of RP902, an oral small-molecule drug developed to address significant unmet medical needs in patients with Alzheimer's disease.

Ranger tilt-back tire changer accessory improves productivity and prevents damage 

GAITHERSBURG, Md., May 19, 2026 (GLOBE NEWSWIRE) -- Amplexd Therapeutics, Inc. (“Amplexd”), a U.S.-based clinical-stage biotechnology company focused on women’s health and underserved therapeutic areas, today announced authorization from the Hong Kong Department of Health to initiate a Phase 2 clinical trial evaluating its novel EGCg-based investigational therapy for precancerous cervical lesions associated with high-risk human papillomavirus (hr-HPV).

ROCHESTER, NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Syntec Optics Holdings, Inc. (Nasdaq: OPTX) (“Syntec” or the “Company”), a leading provider of products for defense tech, space tech, and other vibrant end markets, today announced a series of pioneering product delivery milestones that have taken nearly 12 months to achieve. The Company has successfully manufactured and delivered next-generation products operating at the leading edge and frontier, achieving high accuracy in nanoscale irregularity across highly complex defense, space, and Artificial Intelligence platforms. 

LIMASSOL, Cyprus, May 19, 2026 (GLOBE NEWSWIRE) -- GDEV Inc. (NASDAQ: GDEV), an international gaming and entertainment company (“GDEV” or the “Company”) released its unaudited financial and operational results for the three-month period ended March 31, 2026.

Zero-trust security for AI agents authorizes every action in real time against full request context, with industry veteran Mark van Oppen joining as CRO to drive enterprise growth

New High-Density Capacity Delivers Scarce Power and Contiguous Space for AI, Cloud, Financial Services and Network-Driven Workloads in New York City

Partnership Powers Monetization and Advertiser Performance Across Predictive Life-Stage Intelligence

Increase in stockholder equity and note extension strengthen Company’s ability to advance pancreatic cancer development strategy

WALTHAM, Mass., May 19, 2026 (GLOBE NEWSWIRE) -- Ardelyx Inc. (Nasdaq: ARDX), (“Ardelyx” or the “Company”) a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today announced its participation in a fireside chat at the Jefferies Global Healthcare Conference 2026 on June 3 at 9:55 a.m. ET in New York.

Award Advances AML's Multi-Phase Partnership with the U.S. Government and Further Establishes the Company's PM-Wire™ Manufacturing Process as a Backbone of Domestic Permanent Magnet Production

Transaction Expands Phoenix Lighting's Industrial and Commercial Lighting Portfolio and Strengthens Its Position as a Leading Manufacturer of Specification-Grade Lighting Solutions

The first coaching capability in the market to deliver face-to-face, spoken coaching from a digital human, turning every practice session into an immediate and personal coaching conversation

Milestone advances commercial and manufacturing readiness ahead of anticipated pivotal study scale-up

RALEIGH, N.C., May 19, 2026 (GLOBE NEWSWIRE) -- When pgBackRest's primary maintainer announced he would step away due to a lack of sustainable funding, Percona didn't wait. The open source database company today announced it has joined a group of companies to sponsor pgBackRest, one of PostgreSQL's most widely used backup and recovery tools, restoring active development and giving users a clear path forward.

Liminal’s independent buyer-led research positions Shufti among the highest-scoring vendors on Product Execution, Strategy, and Market Presence, citing its risk-based age assurance, sub-second inference, and privacy-preserving on-device capabilities

More than 2,600 Chrysler, Dodge, Jeep, Ram, FIAT, and Alfa Romeo dealerships will gain access to AI-powered fraud prevention and real-time identity verification directly inside the Stellantis MarketCenter platform

LAS VEGAS, May 19, 2026 (GLOBE NEWSWIRE) -- TON Strategy Company (“TON Strategy” or the “Company”) (Nasdaq: TONX), a digital asset treasury company dedicated to supporting the TON ecosystem, today spotlighted the recent introduction of Acton, a new integrated developer toolchain for The Open Network (“TON”). Acton is designed to simplify how developers build, test, debug, deploy and audit TON-based smart contract applications and is intended to support the next generation of AI-native and agentic applications on the TON blockchain.

Veteran physician, medical affairs and clinical research leader brings 30 years of rehabilitation medicine experience and deep expertise in neuroscience, mobility technologies, and metabolic disease

Veteran biotechnology executive with more than 20 years of leadership experience spanning research, clinical development, commercialization and company building

Vancouver, BC, May 19, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) announces that, subject to regulatory approval, it has entered into an agreement dated May 15, 2026 with North Star Investor Relations Inc. (“North Star”) pursuant to which the Company has engaged the services of North Star to provide investor relations and marketing services, beginning on May 15, 2026. 

The annual Buyer's Choice Awards recognize top-rated brands across key consumer categories, based on in-depth analysis of customer reviews published on ConsumerAffairs.com

10 Companies Selected to Receive Up to $50,000 Each and Accelerate Commercialization of Climate Technologies

SINGAPORE, May 19, 2026 (GLOBE NEWSWIRE) -- Jenfi, a Southeast Asia-focused SME credit platform, today announced that it has surpassed US$100 million in cumulative financing originations across the region, marking a significant milestone in the company’s continued expansion across Singapore and Vietnam.

TORONTO, May 19, 2026 (GLOBE NEWSWIRE) -- Hudbay Minerals Inc. (“Hudbay” or the “Company”) (TSX, NYSE: HBM) today announced the release of its 2025 annual report (“Annual Report”), which provides updates on key business, financial and sustainability initiatives and accomplishments from last year. The sustainability disclosure in the Annual Report is aligned with recognized global reporting standards.

Webcast will be held Thursday, May 21, 2026, at 5:30 p.m. ET

PERTH, Australia, May 19, 2026 (GLOBE NEWSWIRE) -- via IBN -- Globavend Holdings Limited (NASDAQ: GVH) (“Globavend” or the “Company”), an emerging e-commerce logistics provider and digital entertainment company, today announced the appointment of Fuk Yan Tse, known as Sharon Tse (“Ms. Tse” or “Sharon”), as Chief Executive Officer of Loomi Group, the operating arm of the Company’s digital entertainment business. This newly created position follows the Company’s transformational move into the digital entertainment industry. Ms. Tse will oversee the operations and strategy of the Company’s digital entertainment business following the completion of the acquisition of Loomi Entertainment Group Limited and its subsidiaries (“Loomi Group”).

CINCINNATI, Ohio, May 19, 2026 (GLOBE NEWSWIRE) -- Onconetix, Inc. (NASDAQ: ONCO) (“Onconetix” or the “Company”), a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for oncology, today announced that its Board of Directors (the “Board of Directors” or “Board”) has approved a 1-for-10 reverse stock split of its outstanding shares of common stock, to be effective as of 12:01 a.m. Eastern Time on May 21, 2026.

AURORA, Ontario, May 19, 2026 (GLOBE NEWSWIRE) -- Magna has been awarded a Driver and Occupant Monitoring System (DMS/OMS) program with a European OEM. The program marks a significant expansion of Magna’s DMS/OMS across global vehicle platforms and positions the company’s mirror-integrated system as a foundational element within next-generation vehicle architecture.

Garching / Munich, May 19, 2026 –– ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that dosimetry data from its Phase 3 COMPETE trial will be provided in a poster presentation at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, held from May 30 - June 2, 2026 in Los Angeles, California. ITM will also host a satellite symposium on the evolution of SSTR-targeted radiopharmaceutical therapy.Poster Presentation DetailsTitle: Accurate single-time-point dosimetry of [177Lu]Lu-edotreotide using non-linear mixed-effects modeling: results from the COMPETE Phase 3 trialDisplay Date and Location: May 31 – June 2 at the SNMMI Science PavilionSatellite Symposium DetailsTitle: ITM Dinner Symposium – The Evolution of SSTR‑Targeted Therapy – from Agonists to Antagonists and Emerging RadionuclidesObjective: Discuss the evolution of SSTR‑targeted radiopharmaceutical therapy; spanning early approaches, current ¹⁷⁷Lu agonist therapies to next‑generation ligand biology and emerging radionuclides – linking today’s clinical practice with future therapeutic directionsSpeaker: Dr. Julia Fricke, MD, Clinic for Radiology and Nuclear Medicine at the University Hospital Basel, SwitzerlandDate: May 31, 2026, 6:30 PM - 7:30 PM PTLocation: Petree Hall C, LA Convention Center, Los Angeles, CADuring the conference, ITM will exhibit its innovative isotope portfolio, including Lutetium-177, Actinium-225 and Terbium-161. Attendees will have the opportunity to learn more about the company’s innovative radiopharmaceutical pipeline and its capabilities in the manufacturing and supply of radioisotopes at booth #1523.About the COMPETE TrialThe COMPETE trial (NCT03049189) evaluated 177Lu-edotreotide (ITM-11), a proprietary, synthetic, targeted radiotherapeutic investigational agent compared to everolimus, a targeted molecular therapy, in patients with inoperable, progressive Grade 1 or Grade 2 gastroenteropancreatic neuroendocrine tumors (GEP-NETs). This trial met its primary endpoint, with 177Lu-edotreotide demonstrating clinically and statistically significant improvement in progression-free survival (PFS) compared to everolimus. 177Lu-edotreotide is an investigational product pending review by the U.S. Food and Drug Administration (FDA) and is not approved by any regulatory authority for the safety and/or efficacy of any intended use. It is also being evaluated in COMPOSE (NCT04919226), a Phase 3 study in patients with well-differentiated, aggressive Grade 2 or Grade 3, somatostatin receptor (SSTR)-positive GEP-NETs.About ITM Isotope Technologies Munich SEITM, a leading radiopharmaceutical biotech company, is dedicated to providing a new generation of radiopharmaceutical therapeutics and diagnostics for hard-to-treat tumors. We aim to meet the needs of cancer patients, clinicians and our partners through excellence in development, production and global supply of medical radioisotopes. With improved patient benefit as the driving principle for all we do, ITM advances a broad precision oncology pipeline, including multiple Phase 3 studies, combining the company’s high-quality radioisotopes with a range of targeting molecules. By leveraging our two decades of pioneering radiopharma expertise, central industry position and established global network, ITM strives to provide patients with more effective targeted treatment to improve clinical outcome and quality of life. www.itm-radiopharma.comITM ContactCorporate CommunicationsKathleen Noonan/Julia WestermeirPhone: +49 89 329 8986 1500Email: communications@itm-radiopharma.comInvestor RelationsBen OrzelekPhone: +49 89 329 8986 1009Email: investors@itm-radiopharma.com

SCHAUMBURG, Ill. and DALLAS, May 19, 2026 (GLOBE NEWSWIRE) -- The Society of Urologic Oncology Clinical Trials Consortium (SUO-CTC), a national alliance of leading academic and community based uro-oncologists, and CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients with bladder cancer, today announced the recipients of the second annual CG-SUO-CTC NMIBC Research Fellowship designed to support the development of outstanding clinical cancer research investigators who have demonstrated a commitment to improving the understanding and treatment of Non-Muscle Invasive Bladder Cancer (NMIBC). They include:

~ Real-time on the satellite. Analytics across the fleet. Same brain. New frontier. ~

PHILADELPHIA, PA, May 19, 2026 (GLOBE NEWSWIRE) -- Exyn Technologies (“Exyn” or the “Company”) (NASDAQ: EXYN, EXYNW), a leader in autonomous mapping and perception-driven navigation for complex, GPS-denied environments, today announced it executed a Vendor Loan Agreement with the United States Special Operations Command (USSOCOM) to establish a pathway for future adoption of Range’s autonomy systems. Range also entered an agreement with Asylon Robotics to support the U.S. Air Force Warner Robins Air Logistics Complex, applying ExynAI to autonomous inspection and operational efficiency programs within the Organic Industrial Base (OIB).

New solution gives engineering teams instantaneous control over AI agent behavior in production without redeployment

With the continuous development of artificial intelligence technology and the new energy industry, the digital finance sector is undergoing significant changes. Compared to past participation methods that relied on frequent trading and complex operations, more and more users are focusing on a more stable, intelligent, and efficient digital service experience. The integration of AI automation systems with the green new energy ecosystem is gradually becoming a new direction for industry development.

The collaboration will explore how Integer’s DIGIT COMMAND can layer onto Cellula’s Nexus mission control software through a back-seat driver architecture, supporting adaptive tasking, system awareness and operator confidence in communications-constrained environments

SAN FRANCISCO, May 19, 2026 (GLOBE NEWSWIRE) -- BrainHQ, the premier brain-training platform developed by Posit Science, has earned the Gold Badge from APA Labs – a unit of APA Services, Inc., the companion professional association of the American Psychological Association (APA). This elite status recognizes BrainHQ for excellence in clinical rigor and establishes it as a trusted, evidence-based solution in the crowded and largely unregulated digital mental health marketplace. BrainHQ is currently the third app to earn the Gold Digital Badge, and is the first app focused on brain training for cognitive enhancement.

TRUE-See’s patented technology is designed to make medical photography accurate, reliable and easily accessible

New Research Showing 26.5% AI Product-Review Distortion and 60% Hallucination Rates Proves Commerce Needs Verified Intelligence

MORRISVILLE, N.C., May 19, 2026 (GLOBE NEWSWIRE) -- Science 37 today announced the publication of a new analysis in Applied Clinical Trials in collaboration with the Tufts Center for the Study of Drug Development (Tufts CSDD). The study evaluates the performance of Science 37’s Direct-to-Patient (DTP) Site against established industry benchmarks, providing an empirical assessment of how the DTP site model, when added along with traditional sites, can improve study performance.

Toronto, Ontario, May 19, 2026 (GLOBE NEWSWIRE) --

SAN RAMON, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- Arctera and Enterprise Vault, both business units of Cloud Software Group, today announced the appointment of three new sales leaders to support continued growth across its enterprise compliance and governance portfolios. The appointments include Jeff Thomas as Global Sales Leader for Enterprise Vault, along with Chris Hartley as Americas Sales Leader for Arctera and Brenda Sheahan as International Sales Leader for Arctera.

TORONTO, May 19, 2026 (GLOBE NEWSWIRE) -- Mattr Corp. (“Mattr” or the “Company”) (TSX: MATR) announced today in accordance with Toronto Stock Exchange requirements, the voting results from its Annual Meeting held May 14, 2026 in Toronto, Ontario.

WASHINGTON, May 19, 2026 (GLOBE NEWSWIRE) -- Compass Lexecon, a subsidiary of FTI Consulting, Inc. (NYSE: FCN), today announced that Anja Lambrecht, a Professor of Marketing at London Business School, and Matthew Notowidigdo, the David McDaniel Keller Professor of Economics at the University of Chicago Booth School of Business, have affiliated with the firm.

LOUISVILLE, Ky., May 19, 2026 (GLOBE NEWSWIRE) -- Creative Realities, Inc. (“Creative Realities,” “CRI,” or the “Company”) (NASDAQ: CREX), a leading provider of digital signage, media and AdTech solutions, today announced that it will participate in the 23rd Annual Craig-Hallum Institutional Investor Conference in Minneapolis on Thursday, May 28, at the Depot Renaissance Hotel. The day will consist of one-on-one meetings with management, and institutional investors can contact Craig-Hallum directly to set up time with the Company.

Landmark research data reveals new businesses remain the engine of growth, creating more than 3 million jobs per year

WILMINGTON, Del., May 19, 2026 (GLOBE NEWSWIRE) -- Global Indemnity Group, LLC (NASDAQ: GBLI) (“GBLI”) today announced the appointment of Michele Colucci to its Board of Directors, effective May 18, 2026.

MIAMI, FL, May 19, 2026 (GLOBE NEWSWIRE) -- RenX Enterprises Corp. (NASDAQ: RENX) (“RenX” or the “Company”) today announced three operational updates supporting the planned deployment of the Microtec UTM 1200 Turbo Mill at its Myakka City, Florida facility: (1) the initiation of an customer sample run at MTDH Germany GmbH (“Microtec”); (2) the acquisition of a spare parts package bundled with the mill and (3) the funding of contract deposits to the Company’s site commissioning and electrical infrastructure partners.

– Alterity’s novel imaging and biomarker approach positions the Company at the forefront of clinical research in MSA – 

SANTA CLARA, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- SiTime Corporation (“SiTime”) (NASDAQ: SITM), the Precision Timing company, today announced its intent to offer, subject to market conditions and other factors, $1.1 billion aggregate principal amount of Convertible Senior Notes due in 2031 (the “Notes”) in an underwritten offering (the “Offering”). SiTime also intends to grant the underwriters of the Notes a right to purchase, within a 13-day period beginning on, and including, the date on which the Notes are first issued, up to an additional $150 million aggregate principal amount of Notes, solely to cover over-allotments, if any.

- Safety and efficacy results from the Phase 3 INDIGO trial to be presented by Emanuel Della Torre, M.D., Ph.D., on Thursday June 4, 2026, at 2:45 PM GMT -

Survey of 300 food and beverage leaders shows rising investment in automation and traceability, yet a persistent gap remains between strategy and execution

SINGAPORE, May 19, 2026 (GLOBE NEWSWIRE) -- Antalpha Platform Holding Company (NASDAQ: ANTA) ("Antalpha" or the "Company") today announced its unaudited financial results for the first quarter ended March 31, 2026.

CHICAGO, May 19, 2026 (GLOBE NEWSWIRE) -- Vanqua Bio, a clinical-stage biopharmaceutical company, announced that the company will present interim data from its Phase 1b study at World Parkinson’s Congress and the GBA1 Meeting 2026, both taking place in Phoenix, AZ May 22nd – May 27th.

BOSTON, May 19, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ("Tiziana"), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces updated clinical data from its ongoing Expanded Access ("EA") Program evaluating intranasal foralumab in 14 patients with non-active Secondary Progressive Multiple Sclerosis (na-SPMS). The data, updated from March 2025 to as of March 2026, demonstrate that intranasal foralumab continues to be extremely well tolerated over extended treatment durations. Patients showed encouraging trends in stabilization of disability as measured by the Expanded Disability Status Scale (EDSS) and meaningful improvements in fatigue as measured by the Modified Fatigue Impact Scale (MFIS).